OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
425
Results
Show all
Save search
Copy query
Show results for
Unknown
(415)
Proteomics
(7)
Transcriptomics
(2)
Genomics
(1)
Organisms
Mus musculus
(3)
Arabidopsis thaliana
(2)
Homo sapiens
(2)
Escherichia coli str. K-12 substr. MG1655
(1)
Repository
pride
(5)
biostudies-arrayexpress
(3)
MassIVE
(2)
Tissue
Seedling
(2)
Breast
(1)
Epithelial cell
(1)
HeLa cell
(1)
Disease
Breast cancer
(1)
Cervix carcinoma
(1)
Technology Type
Mass Spectrometry
(5)
Shotgun proteomics
(3)
Bottom-up proteomics
(2)
Data-dependent acquisition
(2)
Affinity purification coupled with mass spectrometry proteomics
(1)
Instrument Platform
LTQ Orbitrap Velos
(1)
Q Exactive
(1)
TimsTOF HT
(1)
Publication Date
2025
(3)
2016
(1)
2015
(1)
2014
(1)
2019
(1)
2026
(1)
2023
(1)
2020
(1)
Study type
Transcription profiling by array
(2)
Methylation profiling by high throughput sequencing
(1)
Release Date
2021
(52)
2022
(46)
2025
(45)
2020
(37)
2024
(36)
2023
(34)
2019
(34)
2015
(25)
2018
(23)
2017
(15)
2014
(13)
2016
(12)
2013
(10)
2011
(7)
2026
(6)
2012
(6)
2008
(4)
2010
(3)
2009
(3)
2007
(3)
2006
(2)
2004
(1)
2003
(1)
Lab affiliation
1 Proteomics Facility, Netherlands Cancer Institute, Amsterdam, Netherlands. 2 Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, The Netherlands.
(1)
Department of Chemistry, The Scripps Research Institute, Jupiter, FL 33458, USA
(1)
Group leader Cell and Developmental Biology John Innes Centre Norwich Research Park Norwich, UK
(1)
Research Professor Cell and Developmental Biology John Innes Centre Norwich Research Park Norwich, UK
(1)
Stanford University School of Medicine 279 Campus Drive Stanford, CA 94305-5323
(1)
Previous
page
1 / 43
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
43
Next
page
Sort
by:
Relevance
Page size
10
Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890.
Not available
S-EPMC9626947
|
biostudies-literature
Cite
A novel HLA-A*0201 restricted peptide derived from cathepsin G is an effective immunotherapeutic target in acute myeloid leukemia.
Not available
S-EPMC3537920
|
biostudies-literature
Cite
Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target.
Not available
S-EPMC5215491
|
biostudies-literature
Cite
Risk factors for left ventricular dysfunction in adulthood: role of low birth weight.
Not available
S-EPMC8712853
|
biostudies-literature
Cite
Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS.
Not available
S-EPMC6709999
|
biostudies-literature
Cite
Insulin Production and Resistance in Different Models of Diet-Induced Obesity and Metabolic Syndrome.
Not available
S-EPMC5343821
|
biostudies-literature
Cite
Subcortical deep gray matter pathology in patients with multiple sclerosis is associated with white matter lesion burden and atrophy but not with cortical atrophy: a diffusion tensor MRI study.
Not available
S-EPMC7964539
|
biostudies-literature
Cite
No association between conventional brain MR imaging and chronic cerebrospinal venous insufficiency in multiple sclerosis.
Not available
S-EPMC7964624
|
biostudies-literature
Cite
Depleting the Action of EZH2 through PI3K-mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer.
Not available
S-EPMC12485387
|
biostudies-literature
Cite
The Hairpin Form of r(G
4
C
2
)
exp
in c9ALS/FTD Is Repeat-Associated Non-ATG Translated and a Target for Bioactive Small Molecules.
Not available
S-EPMC6386614
|
biostudies-literature
Cite
Previous
page
1 / 43
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
43
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
